Headache is one of the most common presenting symptoms in primary care and represents a high proportion of patients referred to a neurology specialist. Poorly managed acute headaches can lead to a chronicity of symptoms, and poorly managed chronic headaches can lead to depression, lost productivity, and reduced quality of life. Nurse Practitioners need to know how to differentiate primary versus secondary headaches, particularly when s secondary headache can be the result of a serious life limiting condition. Thankfully the vast majority of headaches presenting in primary care are of the “primary” variety and knowledge of management with pharmacotherapies and non-pharmacotherapies is vital to a primary care practice. This lecture will focus on the most up to date pharmacotherapies available for primary headache disorders. | 1.50 credits (1.25 Pharmacology) | $40

In 2019, the Infectious Disease Society of America and American Thoracic Society published updated recommendations for managing patients with community-acquired pneumonia (CAP) generating new considerations for inpatient and outpatient practitioners. This presentation will assess emerging literature influencing the optimal pharmacologic management of CAP such as, changing etiologic trends, patient-specific factors, outcomes evidence, and risk factors for adverse drug reactions. | 1.50 credits (1.50 Pharmacology) | $40

This presentation will review pharmacological management of the common types of hypo and hyperthyroidism along with an overview of thyroid hormones and their effect on the hypothalamic-pituitary-thyroid axis. | 1.50credits (1.50 Pharmacology) | $40

Update on treatment of migraines utilizing case studies. | 1.50 credits (1.50 Pharmacology) | $40

The management of type 2 diabetes involves a multifaceted approach to control blood sugar levels and mitigate complications. Lifestyle modifications are crucial, including a balanced diet, regular exercise, and weight management. Medications like metformin, has been the mainstay of type 2 diabetes management. Over the past several years, guidelines have shifted away from a glucose centric focus to prioritizing cardio-renal management. Therapeutic inertia has created a situation where our type 2 diabetic patients are increasingly not reaching their A1C goals and under-prescribed appropriate goal directed medications. | 1.5 credits (1.50 Pharmacology) | $40

This presentation analyzes the most current guidelines for the management of dyslipidemia for both a primary prevention and for risk reduction in the patient who has already had a coronary artery event. Evaluation of the mechanisms of action of the newest lipid-lowering agents is presented in setting of clinical relevant case studies to provide | 1.50 credits (1.50 Pharmacology) | $45

The etiology of sleep disorders is multimodal. Most patients with chronic sleep disorders usually have a combination of physiologic, psychologic, and environmental causes. This presentation reviews pharmacotherapeutic options as they apply to the wide variety of physiologic causes. | 1.5 credits (0.75 Pharmacology) | $35

This presentation will review the pharmacological options for the treatment of obesity, review lifestyle intervention prescribing, discuss weight loss targets for the reduction of cardiovascular disease and diabetes progression. | 1.50 credits (1.10 Pharmacology) | $40

This presentation discusses updated diagnostic criteria and psychometric approaches to improve case identification, diagnosis & treatment of attention deficit-hyperactivity disorders. ADHD is redefined in the context of epigenetics and neurobiology, with specific attention to contemporary pharmacological approaches to manage the symptoms. Practical applications for nurse practitioners are presented. | 1.0 credits (0.66 Pharmacology) | $30

The purpose of this workshop is to provide NP’s an update on the treatment of patients with HIV. It will include an overview of the issues that have impacted the uptake and use of PrEP, the newest mediations available for treatment, and a brief discussion on the impact of the end the epidemic initiatives. | 1 credits (0.75 pharmacology) | $30